Keywords: vicuron, reduce, costs, due, anidulaflungin, delay, pharmaceuticals

Vicuron to reduce costs due to anidulaflungin delay

Article | 28 June 2004

Print This

Vicuron Pharmaceuticals of the USA has announced details of its plan to reduce operating expenses in light of the delay ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in